Clarifying omega-3 fatty acid recommendations.
Biro
Andy
A
D002318:Cardiovascular Diseases / Q000517:prevention & control; D019587:Dietary Supplements / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008297:Male; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000209:etiology*; D018570:Risk Assessment; D006113:United Kingdom / Q000453:epidemiology
D015525:Fatty Acids, Omega-3